The definitive treatment for symptomatic large volume (>80 mL) benign prostatic hyperplasia (BPH) is simple prostatectomy (SP). This can be performed by utilizing a retropubic, suprapubic, or a combined approach. The latter two approaches allow for the management of concomitant bladder diverticulum or stones through the same incision. Each approach affords unique technical strengths and weaknesses that must be considered in light of patient characteristics and concomitant pathology. SP allows for removal of the entire prostatic adenoma while obviating some of the neurovascular and continence issues that can arise from radical prostatectomy. Concerns with SP include its relatively high perioperative morbidity, notably bleeding. Therefore, there is increasing interest in less invasive options, including enucleation procedures and minimally invasive SP. This review presents an update regarding trends and outcomes of SP, as well as the effectiveness and popularity of alternative treatments.
Current urology reports. 2016 Aug [Epub]
Joseph J Pariser, Vignesh T Packiam, Melanie A Adamsky, Gregory T Bales
Section of Urology, Department of Surgery, The University of Chicago Medicine, 5841 S. Maryland Ave. MC6038, Chicago, IL, 60637, USA., Section of Urology, Department of Surgery, The University of Chicago Medicine, 5841 S. Maryland Ave. MC6038, Chicago, IL, 60637, USA., Section of Urology, Department of Surgery, The University of Chicago Medicine, 5841 S. Maryland Ave. MC6038, Chicago, IL, 60637, USA., Section of Urology, Department of Surgery, The University of Chicago Medicine, 5841 S. Maryland Ave. MC6038, Chicago, IL, 60637, USA. .